Sertraline effectiveness in prevention of depression in MS patients.
Phase 2
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT2015090723927N1
- Lead Sponsor
- Vice chancellor for research,Tabriz university of medical science.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion Criteria:
Age 15-60;Primary education Exclusion;
Other Organic illnesses:Other mental disorder;Smoking and substance induce or alcohol abuser.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depresion. Timepoint: Atfirst of study, 1 mth later, 3mth later, 6 mth later. Method of measurement: Hamilton Questionnaire.;Decreament OF Fatigue. Timepoint: Atfirst of study, 1 mth later, 3mth later, 6 mth later. Method of measurement: SF_36 Questionnaire.;Quality of life. Timepoint: Atfirst of study, 1 mth later, 3mth later, 6 mth later. Method of measurement: FSS Questionnaire OF QOL.
- Secondary Outcome Measures
Name Time Method Probably switch to mania. Timepoint: During fallow up times. Method of measurement: Based on DSM criteria.